Back to Search
Start Over
Extent of Drug Patents With Terminal Disclaimers and Obviousness-Type Double Patenting Rejections.
- Source :
-
JAMA: Journal of the American Medical Association . 9/10/2024, Vol. 332 Issue 10, p837-838. 2p. - Publication Year :
- 2024
-
Abstract
- This study evaluates the frequency of terminal disclaimers filed by drug patent holders to obviate obviousness-type double patenting rejections associated with drug patent thickets. [ABSTRACT FROM AUTHOR]
- Subjects :
- *DRUG patents
*DISCLAIMERS
*PATENTS
Subjects
Details
- Language :
- English
- ISSN :
- 00987484
- Volume :
- 332
- Issue :
- 10
- Database :
- Academic Search Index
- Journal :
- JAMA: Journal of the American Medical Association
- Publication Type :
- Academic Journal
- Accession number :
- 179640441
- Full Text :
- https://doi.org/10.1001/jama.2024.14350